Company News

Peak Proteins Company News Archives

Peak Proteins Welcomes Naimah Begum

2020-11-16T17:45:38+00:00September 28th, 2020|Company News|

Peak Proteins welcomes Naimah Begum who joins us as a Protein Scientist. Naimah has just recently graduated from the University of Manchester with a BSc in microbiology, thoroughly enjoying the aspects of bacteriology and infection. Through numerous reports she [...]

Peak Proteins Welcomes Dr Ravneet Mandair

2024-07-31T14:50:11+00:00September 28th, 2020|Company News|

Peak Proteins welcomes Dr Ravneet Mandair who joins us as a Protein Purification Specialist. Rav studied for a BSc at Aston University in Birmingham UK in microbiology and immunology.  Modules on her course included food microbiology, applied molecular biology [...]

Bruntwood SciTech Innovation Video

2024-09-30T14:23:10+00:00June 4th, 2020|Company News|

Peak Proteins were delighted to be included among the great companies innovating in the Bruntwood SciTech community as we work on identifying target receptors for COVID-19 with our collaborators the Medicines Discovery Catapult and Retrogenix.

Customer Interview with Dr Ben Bax

2020-05-28T10:10:43+00:00May 27th, 2020|Company News|

Dr Ben Bax first approached Peak Proteins in 2019 for support in expressing glutamate receptors for structural determination.  Dr Hazel Weir recently caught up with him by Zoom to discuss the project. Ben is a Reader in Structural Biology at [...]

Peak Proteins Welcomes Richard Mott

2020-04-28T13:00:36+00:00April 28th, 2020|Company News|

Peak Proteins welcomes Richard Mott who joins us as a Business Development Associate working with our Head of Scientific Business Development, Dr Hazel Weir. Richard has worked in the world of protein science for many years and already knows some [...]

Medicines Discovery Catapult, Retrogenix and Peak Proteins Collaborate to Identify Target Receptors for COVID-19

2020-04-27T12:50:35+00:00April 27th, 2020|Company News|

Medicines Discovery Catapult, Retrogenix and Peak Proteins announce a collaboration to advance understanding of the cellular mechanisms of infection by COVID-19. This collaboration aims to combine excellence in drug discovery and protein science with innovative cellular microarray technology to uncover any unknown cellular [...]

Go to Top